Developer docs
API playgroundTry for free, no card

Search company profiles

ARTELLA Solutions, Inc.

Full company profile

uuid000c2gp

Namestring
ARTELLA Solutions, Inc.
Legal namestring
Artella Solutions Inc.
Websiteurl
artellainc.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

ARTELLA Solutions, Inc. is a Houston, Texas-based digital healthcare company that provides remote cardiac monitoring services to healthcare providers, physician practices, and cardiology groups across the United States. Founded in 2012 and operating as a wholly owned subsidiary of CorMedica Group, the company is structured as a certified Independent Diagnostic Testing Facility (IDTF), which enables it to directly bill Medicare and commercial payers for Mobile Cardiac Telemetry (MCT) and related cardiac monitoring services. End users of its monitoring patches are patients with rhythm disorders, including atrial fibrillation (AFib), post-ablation patients, and individuals at risk of stroke or TIA. The company employs 50+ people following a major restructuring executed by returning co-founder and CEO Sepand Moshiri in late 2021.

ARTELLA's core product is the Active State Monitoring (ASM/MoS) platform — a device-agnostic, cloud-based SaaS solution that continuously collects and live-streams ECG data from proprietary wearable patches. The flagship hardware is the V-Patch, available in 5-day and 14-day rechargeable, shower-resistant variants, plus the 7-day coin-battery S-Patch. Both patches consolidate six monitoring modalities (Holter, Extended Holter, Event, MCT, Holter+Event, and Holter+MCT) into a single 6-in-1 device. The platform is augmented by proprietary MCOT (Mobile Cardiac Outpatient Telemetry) algorithms for arrhythmia detection, an "Elite Customer Service" layer staffed by certified cardiology medical assistants and certified cardiographic technicians (CCI), the Cor-AI diagnostic intelligence module (machine-learning-based ECG interpretation), and a recently launched CardioSleep module (via partnership with PranaQ) that integrates FDA-cleared home sleep testing for Obstructive Sleep Apnea detection alongside cardiac monitoring. The platform integrates into existing EMR/EHR systems and athenahealth-powered billing workflows.

ARTELLA generates revenue through three provider payment models: a split-bill model in which the company (as IDTF) directly bills patient insurance with no upfront cost to the provider; a subscription model in which providers license Artella's equipment and software; and a report fee model in which providers purchase hardware, service, and reports. Distribution is primarily direct enterprise field sales targeting healthcare providers, augmented by channel partnerships (Wellysis for S-Patch ExL distribution; Future Cardia for implantable monitors; PranaQ for sleep diagnostics; VivaLink for ambulatory cardiac monitoring) and strategic technology integrations (athenahealth for billing). The company has expanded from its Texas homebase into six or more states, is pursuing a Series A2 capital raise, and is targeting $12 million in revenue within the next year with an IPO pathway flagged by mid-to-late 2025.

Short descriptiontext

ARTELLA Solutions is a Houston-based digital healthcare company operating as a certified IDTF that delivers remote cardiac monitoring through a device-agnostic SaaS platform, proprietary 6-in-1 wearable patches, and AI/ML-driven ECG analysis for healthcare providers and cardiology practices across multiple U.S. states.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHouston, United States
HQ citystring
Houston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
remote cardiac monitoring, mobile cardiac telemetry, cardiac diagnostic platform, ECG monitoring devices, arrhythmia detection services
Industry3 codes
PRIMARYHLAHACAB
Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAGAB
Cardiology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
NAICS code2 codes
  • Testing Laboratories and Services54138
  • Testing Laboratories and Services541380
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Medical Laboratories8071
  • Instruments For Meas & Testing Of Electricity & Elec Signals3825
Product category
Remote Cardiac Monitoring Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Mobile Cardiac Telemetry (MCT) Services
TypeSubscription Recurring
Description

Direct billing for MCT monitoring services as a certified Independent Diagnostic Testing Facility (IDTF). Artella bills patients' insurance (Medicare or Commercial payor) directly for patient services under the split-bill model.

artellainc.com
2Technology Licensing (Subscription Model)
TypeSubscription Recurring
Description

Providers access Artella's technology through a license for equipment and software, paying a subscription fee for technology access.

artellainc.com
3Report Fee Model
TypeProfessional Services
Description

Providers purchase the product, customer service, and report services. Revenue generated from report fees and service charges.

artellainc.com
4Hardware Sales
TypeHardware Sales
Description

Sale of cardiac monitoring patch devices (V-Patch, S-Patch) to healthcare providers and clinics.

artellainc.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Pricing details3 tiers
1Split-bill: Artella as IDTF directly bills patient insurance
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Artella is a certified IDTF and directly bills patients' insurance (Medicare or Commercial payor) for patient services. No upfront cost to provider.

artellainc.com
2Subscription: Provider licenses Artella technology
ModelSubscriptionBilling cadenceMonthly
Notes

Providers access Artella's technology with a license for equipment and software. Subscription-based access to the platform and devices.

artellainc.com
3Report Fee: Provider purchases product, service and reports
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Providers purchase the product, customer service, and report services outright. Report fees generated per study.

artellainc.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1CARDIOSLEEP
Description

A unified sleep diagnostic solution integrated into Artella's Active State Monitoring platform, offered through partnership with PranaQ for cardiology practices to manage Obstructive Sleep Apnea and cardiac conditions.

artellainc.com
Core offering1 text field

ARTELLA Solutions provides remote cardiac monitoring through a device-agnostic Active State Monitoring SaaS platform paired with proprietary V-Patch and S-Patch wearable hardware that combines six monitoring modalities (Holter, Extended Holter, Event, MCT, Holter+Event, Holter+MCT) in a single device. Operating as a Certified Independent Diagnostic Testing Facility (IDTF), the company delivers real-time ECG data streaming, proprietary MCOT algorithm analysis, 24/7 monitoring by certified technicians, and integrated billing/reimbursement services to healthcare providers and physician practices across multiple U.S. states.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 27% of critical calls to physicians in a 3-month period involved patients entering Atrial Fibrillation at the start of their study
+4 more records
Product overview1 text field

ARTELLA Solutions offers a device-agnostic SaaS platform centered around its Active State Monitoring (MoS) platform with two primary hardware products: the V-Patch (5 or 14-day rechargeable) and S-Patch (7-day coin battery). Both patches provide 6-in-1 monitoring capabilities (Holter, Extended Holter, Event, MCT, Holter+Event, Holter+MCT) with proprietary algorithm analysis. The platform is augmented by Elite Customer Service staffed by certified cardiology technicians, and has expanded into sleep diagnostics via the CARDIOSLEEP module. The Cor-AI Platform brings AI/ML capabilities for cardiac data analysis. The company operates as a Certified Independent Diagnostic Testing Facility (IDTF) providing monitoring services to patients and diagnostic systems to healthcare providers.

Product and service5 records
1Active State Monitoring (ASM) Platform
CategoryCardiac Monitoring Platform
Description

A device-agnostic SaaS platform that provides real-time cardiac monitoring and data analysis, continuously collecting and live-streaming ECG data and enabling physicians and healthcare providers to remotely monitor patients across multiple cardiac monitoring modes through a single integrated system.

2V-Patch Cardiac Monitoring Device
CategoryCardiac Monitoring Hardware
Description

A lightweight, wireless cardiac monitoring patch with 5 or 14 day rechargeable battery life, 6-in-1 monitoring capability (Holter, Extended Holter, Event, MCT, Holter+Event, Holter+MCT), Active-State Monitoring with 100% data stream analysis, and a shower-resistant design for continuous patient monitoring.

3S-Patch Cardiac Monitoring Device
CategoryCardiac Monitoring Hardware
Description

A compact cardiac monitoring patch with 7-day coin battery life designed for extended remote cardiac monitoring. Part of ARTELLA's portfolio of FDA-related monitoring solutions offered through partnerships including the Wellysis S-Patch ExL collaboration.

4CARDIOSLEEP Sleep Diagnostics Module
CategorySleep Diagnostic Module
Description

A sleep diagnostic workflow module integrated into ARTELLA's Active State Monitoring platform that enables cardiology practices to order, track, and manage sleep studies, leveraging PranaQ's FDA-cleared Home Sleep Test system to diagnose Obstructive Sleep Apnea (OSA) and address the clinically proven connection between OSA and Atrial Fibrillation.

5Elite Customer Service
CategoryClinical Support Service
Description

A concierge customer service offering staffed by certified cardiology medical assistants who monitor patient compliance and device/gateway phone battery levels throughout the monitoring session, providing 24/7 patient support throughout the cardiac monitoring experience.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-18
Description

Strategic partnership integrating PranaQ's FDA-cleared Home Sleep Test system into ARTELLA's Active State Monitoring platform. Enables cardiology practices to order, track, and manage sleep studies within ARTELLA's diagnostic ecosystem, branded as CardioSleep. Addresses the clinically proven connection between Obstructive Sleep Apnea (OSA) and Atrial Fibrillation (AFib).

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-13
Description

Expanded strategic collaboration integrating ARTELLA's Active State Monitoring SaaS platform and Certified IDTF with Future Cardia's investigational implantable cardiac monitor. Companies began working together during Future Cardia's pre-FDA phase to facilitate secure ECG data transfer for analysis. Evaluating integration of ARTELLA's platform into Future Cardia's data and workflow ecosystem.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-03-19
Description

Partnership with Wellysis, a digital healthcare spin-off from Samsung, to bring the FDA-approved S-Patch ExL device to the US market. Artella integrates the S-Patch device into its remote cardiac monitoring platform.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

iRhythm's Zio long-term continuous monitoring patch is the category-defining competitor to Artella's V-Patch. Both deliver MCT/Holter-class ambulatory ECG monitoring with proprietary algorithms and IDTF-class reporting services to cardiology practices.

TypeDirect peer
Description

AliveCor's KardiaMobile 6L is a prescription-grade personal ECG device competing for cardiology-prescribed ambulatory monitoring share. While hardware form factor differs (handheld vs patch), both target the same cardiology prescribing workflow with AI-driven ECG interpretation.

TypeBroad incumbent
Description

Boston Scientific acquired Preventice Solutions (BodyGuardian) for ~$720M in 2021. Preventice was the predecessor where much of Artella's current leadership (Lawson, Fitzsimons, Nelson, Ummer) built their careers, making it the closest strategic and operational analog.

TypeBroad incumbent
Description

Spacelabs (OSI Systems subsidiary) provides in-hospital cardiac monitoring, Holter, and ambulatory telemetry products to hospitals and cardiology practices. Comparable to Artella in Holter/MCT product categories but with a broader hospital capital equipment footprint.

TypeDirect peer
Description

ReactDx is a remote cardiac monitoring service provider offering MCT, Event, and Holter services through an IDTF model directly comparable to Artella's split-bill motion. Both compete for cardiology practice and IDTF accounts across overlapping geographies.

TypeDirect peer
Description

Medicomp is a long-standing provider of Holter, Event, and MCT monitoring hardware and software services to cardiology practices. Comparable to Artella in serving mid-market physician practices with multi-modality cardiac monitoring.

TypeBroad incumbent
Description

Philips acquired BioTelemetry for ~$2.8B in 2021, making it one of the largest remote cardiac monitoring service providers in the US. Overlaps with Artella across MCT, Holter, and Event monitoring under the Philips Cardiology Services umbrella.

TypeDirect peer
Description

ScottCare provides cardiovascular diagnostic systems including Holter analysis, event monitoring, and cardiopulmonary stress testing — overlapping with Artella's Holter/Event/MCT modalities in the cardiology practice channel.

TypeDirect peer
Description

HeartcoR is a CRO/ECG core lab providing cardiac safety and Holter analysis services to pharmaceutical sponsors and clinical research organizations. Comparable in ECG algorithm expertise and technician-staffed service model.

TypeDirect peer
Description

Bardy's CAM patch was a direct patch-form-factor competitor to Artella's V-Patch before acquisition by Hillrom (now Baxter). It validated the small-patch MCT category in which Artella now competes.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ARTELLA Solutions, Inc.

Remote Cardiac Monitoring Servicesartellainc.com

ARTELLA Solutions is a Houston-based digital healthcare company operating as a certified IDTF that delivers remote cardiac monitoring through a device-agnostic SaaS platform, proprietary 6-in-1 wearable patches, and AI/ML-driven ECG analysis for healthcare providers and cardiology practices across multiple U.S. states.

What ARTELLA Solutions, Inc. does

ARTELLA Solutions, Inc. is a Houston, Texas-based digital healthcare company that provides remote cardiac monitoring services to healthcare providers, physician practices, and cardiology groups across the United States. Founded in 2012 and operating as a wholly owned subsidiary of CorMedica Group, the company is structured as a certified Independent Diagnostic Testing Facility (IDTF), which enables it to directly bill Medicare and commercial payers for Mobile Cardiac Telemetry (MCT) and related cardiac monitoring services. End users of its monitoring patches are patients with rhythm disorders, including atrial fibrillation (AFib), post-ablation patients, and individuals at risk of stroke or TIA. The company employs 50+ people following a major restructuring executed by returning co-founder and CEO Sepand Moshiri in late 2021.

ARTELLA's core product is the Active State Monitoring (ASM/MoS) platform — a device-agnostic, cloud-based SaaS solution that continuously collects and live-streams ECG data from proprietary wearable patches. The flagship hardware is the V-Patch, available in 5-day and 14-day rechargeable, shower-resistant variants, plus the 7-day coin-battery S-Patch. Both patches consolidate six monitoring modalities (Holter, Extended Holter, Event, MCT, Holter+Event, and Holter+MCT) into a single 6-in-1 device. The platform is augmented by proprietary MCOT (Mobile Cardiac Outpatient Telemetry) algorithms for arrhythmia detection, an "Elite Customer Service" layer staffed by certified cardiology medical assistants and certified cardiographic technicians (CCI), the Cor-AI diagnostic intelligence module (machine-learning-based ECG interpretation), and a recently launched CardioSleep module (via partnership with PranaQ) that integrates FDA-cleared home sleep testing for Obstructive Sleep Apnea detection alongside cardiac monitoring. The platform integrates into existing EMR/EHR systems and athenahealth-powered billing workflows.

ARTELLA generates revenue through three provider payment models: a split-bill model in which the company (as IDTF) directly bills patient insurance with no upfront cost to the provider; a subscription model in which providers license Artella's equipment and software; and a report fee model in which providers purchase hardware, service, and reports. Distribution is primarily direct enterprise field sales targeting healthcare providers, augmented by channel partnerships (Wellysis for S-Patch ExL distribution; Future Cardia for implantable monitors; PranaQ for sleep diagnostics; VivaLink for ambulatory cardiac monitoring) and strategic technology integrations (athenahealth for billing). The company has expanded from its Texas homebase into six or more states, is pursuing a Series A2 capital raise, and is targeting $12 million in revenue within the next year with an IPO pathway flagged by mid-to-late 2025.

ARTELLA Solutions, Inc. firmographics

Firmographics
Name
ARTELLA Solutions, Inc.
Legal name
Artella Solutions Inc.
Website
https://artellainc.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
ARTELLA Solutions is a Houston-based digital healthcare company operating as a certified IDTF that delivers remote cardiac monitoring through a device-agnostic SaaS platform, proprietary 6-in-1 wearable patches, and AI/ML-driven ECG analysis for healthcare providers and cardiology practices across multiple U.S. states.
Ownership category
akta.pro rank

ARTELLA Solutions, Inc. industry classification

Industry
Product category
Remote Cardiac Monitoring Services
NAICS
Testing Laboratories and Services (54138), Testing Laboratories and Services (541380)
SIC
Surgical & Medical Instruments & Apparatus (3841), Services-Medical Laboratories (8071), Instruments For Meas & Testing Of Electricity & Elec Signals (3825)
akta.pro industry
PRIMARYHLAHACAB
Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAGAB
Cardiology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)

Keywords

  • Remote cardiac monitoring
  • Mobile cardiac telemetry
  • Cardiac diagnostic platform
  • ECG monitoring devices
  • Arrhythmia detection services

Where ARTELLA Solutions, Inc. is headquartered

Location

Headquarters

HQ city
Houston
HQ country
United States
HQ region
North America

Offices2 records

Markets served

ARTELLA Solutions, Inc. business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Mobile Cardiac Telemetry (MCT) Services: Direct billing for MCT monitoring services as a certified Independent Diagnostic Testing Facility (IDTF). Artella bills patients' insurance (Medicare or Commercial payor) directly for patient services under the split-bill model.
  2. Technology Licensing (Subscription Model): Providers access Artella's technology through a license for equipment and software, paying a subscription fee for technology access.
  3. Report Fee Model: Providers purchase the product, customer service, and report services. Revenue generated from report fees and service charges.
  4. Hardware Sales: Sale of cardiac monitoring patch devices (V-Patch, S-Patch) to healthcare providers and clinics.

Pricing tiers

ModelBillingPrice
SubscriptionPay-as-you-goSplit-bill: Artella as IDTF directly bills patient insurance
SubscriptionMonthlySubscription: Provider licenses Artella technology
One time/ perpetual licensePay-as-you-goReport Fee: Provider purchases product, service and reports

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

ARTELLA Solutions, Inc. product offering

Product offering

Core offering

ARTELLA Solutions provides remote cardiac monitoring through a device-agnostic Active State Monitoring SaaS platform paired with proprietary V-Patch and S-Patch wearable hardware that combines six monitoring modalities (Holter, Extended Holter, Event, MCT, Holter+Event, Holter+MCT) in a single device. Operating as a Certified Independent Diagnostic Testing Facility (IDTF), the company delivers real-time ECG data streaming, proprietary MCOT algorithm analysis, 24/7 monitoring by certified technicians, and integrated billing/reimbursement services to healthcare providers and physician practices across multiple U.S. states.

Product overview

ARTELLA Solutions offers a device-agnostic SaaS platform centered around its Active State Monitoring (MoS) platform with two primary hardware products: the V-Patch (5 or 14-day rechargeable) and S-Patch (7-day coin battery). Both patches provide 6-in-1 monitoring capabilities (Holter, Extended Holter, Event, MCT, Holter+Event, Holter+MCT) with proprietary algorithm analysis. The platform is augmented by Elite Customer Service staffed by certified cardiology technicians, and has expanded into sleep diagnostics via the CARDIOSLEEP module. The Cor-AI Platform brings AI/ML capabilities for cardiac data analysis. The company operates as a Certified Independent Diagnostic Testing Facility (IDTF) providing monitoring services to patients and diagnostic systems to healthcare providers.

Differentiator

Problem solved

Functional benefit

Brands

  • CARDIOSLEEP: A unified sleep diagnostic solution integrated into Artella's Active State Monitoring platform, offered through partnership with PranaQ for cardiology practices to manage Obstructive Sleep Apnea and cardiac conditions.

Products and services

  • Active State Monitoring (ASM) Platform A device-agnostic SaaS platform that provides real-time cardiac monitoring and data analysis, continuously collecting and live-streaming ECG data and enabling physicians and healthcare providers to remotely monitor patients across multiple cardiac monitoring modes through a single integrated system.
  • V-Patch Cardiac Monitoring Device A lightweight, wireless cardiac monitoring patch with 5 or 14 day rechargeable battery life, 6-in-1 monitoring capability (Holter, Extended Holter, Event, MCT, Holter+Event, Holter+MCT), Active-State Monitoring with 100% data stream analysis, and a shower-resistant design for continuous patient monitoring.
  • S-Patch Cardiac Monitoring Device A compact cardiac monitoring patch with 7-day coin battery life designed for extended remote cardiac monitoring. Part of ARTELLA's portfolio of FDA-related monitoring solutions offered through partnerships including the Wellysis S-Patch ExL collaboration.
  • CARDIOSLEEP Sleep Diagnostics Module A sleep diagnostic workflow module integrated into ARTELLA's Active State Monitoring platform that enables cardiology practices to order, track, and manage sleep studies, leveraging PranaQ's FDA-cleared Home Sleep Test system to diagnose Obstructive Sleep Apnea (OSA) and address the clinically proven connection between OSA and Atrial Fibrillation.
  • Elite Customer Service A concierge customer service offering staffed by certified cardiology medical assistants who monitor patient compliance and device/gateway phone battery levels throughout the monitoring session, providing 24/7 patient support throughout the cardiac monitoring experience.

Quantifiable outcome

  • 27% of critical calls to physicians in a 3-month period involved patients entering Atrial Fibrillation at the start of their study
  • +4 more outcomes

Companies that use ARTELLA Solutions, Inc.

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

ARTELLA Solutions, Inc. technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

ARTELLA Solutions, Inc. partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • PranaQcoreStrategic or Co-development Partner · 18 November 2025Strategic partnership integrating PranaQ's FDA-cleared Home Sleep Test system into ARTELLA's Active State Monitoring platform. Enables cardiology practices to order, track, and manage sleep studies within ARTELLA's diagnostic ecosystem, branded as CardioSleep. Addresses the clinically proven connection between Obstructive Sleep Apnea (OSA) and Atrial Fibrillation (AFib).
  • Future CardiacoreStrategic or Co-development Partner · 13 November 2025Expanded strategic collaboration integrating ARTELLA's Active State Monitoring SaaS platform and Certified IDTF with Future Cardia's investigational implantable cardiac monitor. Companies began working together during Future Cardia's pre-FDA phase to facilitate secure ECG data transfer for analysis. Evaluating integration of ARTELLA's platform into Future Cardia's data and workflow ecosystem.
  • WellysiscoreTechnology or Integration · 19 March 2024Partnership with Wellysis, a digital healthcare spin-off from Samsung, to bring the FDA-approved S-Patch ExL device to the US market. Artella integrates the S-Patch device into its remote cardiac monitoring platform.

Scale indicators6 records

Recent moves8 records

Expansion highlights7 records

ARTELLA Solutions, Inc. competitors and assessment

Company assessment

Direct peers

  • iRhythm Technologies: iRhythm's Zio long-term continuous monitoring patch is the category-defining competitor to Artella's V-Patch. Both deliver MCT/Holter-class ambulatory ECG monitoring with proprietary algorithms and IDTF-class reporting services to cardiology practices.
  • AliveCor: AliveCor's KardiaMobile 6L is a prescription-grade personal ECG device competing for cardiology-prescribed ambulatory monitoring share. While hardware form factor differs (handheld vs patch), both target the same cardiology prescribing workflow with AI-driven ECG interpretation.
  • ReactDx (formerly Cardiac Monitoring Services): ReactDx is a remote cardiac monitoring service provider offering MCT, Event, and Holter services through an IDTF model directly comparable to Artella's split-bill motion. Both compete for cardiology practice and IDTF accounts across overlapping geographies.
  • Medicomp: Medicomp is a long-standing provider of Holter, Event, and MCT monitoring hardware and software services to cardiology practices. Comparable to Artella in serving mid-market physician practices with multi-modality cardiac monitoring.
  • ScottCare: ScottCare provides cardiovascular diagnostic systems including Holter analysis, event monitoring, and cardiopulmonary stress testing — overlapping with Artella's Holter/Event/MCT modalities in the cardiology practice channel.
  • HeartcoR Solutions: HeartcoR is a CRO/ECG core lab providing cardiac safety and Holter analysis services to pharmaceutical sponsors and clinical research organizations. Comparable in ECG algorithm expertise and technician-staffed service model.
  • Bardy Diagnostics (Baxter/Hillrom): Bardy's CAM patch was a direct patch-form-factor competitor to Artella's V-Patch before acquisition by Hillrom (now Baxter). It validated the small-patch MCT category in which Artella now competes.

Broad incumbents

  • Boston Scientific (Preventice Solutions): Boston Scientific acquired Preventice Solutions (BodyGuardian) for ~$720M in 2021. Preventice was the predecessor where much of Artella's current leadership (Lawson, Fitzsimons, Nelson, Ummer) built their careers, making it the closest strategic and operational analog.
  • Spacelabs Healthcare: Spacelabs (OSI Systems subsidiary) provides in-hospital cardiac monitoring, Holter, and ambulatory telemetry products to hospitals and cardiology practices. Comparable to Artella in Holter/MCT product categories but with a broader hospital capital equipment footprint.
  • Philips (BioTelemetry): Philips acquired BioTelemetry for ~$2.8B in 2021, making it one of the largest remote cardiac monitoring service providers in the US. Overlaps with Artella across MCT, Holter, and Event monitoring under the Philips Cardiology Services umbrella.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

ARTELLA Solutions, Inc. social profiles

Digital presence

ARTELLA Solutions, Inc. compliance and trust

Trust signal

Compliance3 records

ARTELLA Solutions, Inc. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ARTELLA Solutions, Inc. leadership team

Management profile

Number of profiles

Profiles12 records

ARTELLA Solutions, Inc. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ARTELLA Solutions, Inc. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ARTELLA Solutions, Inc.

What does ARTELLA Solutions, Inc. do?

ARTELLA Solutions provides remote cardiac monitoring through a device-agnostic Active State Monitoring SaaS platform paired with proprietary V-Patch and S-Patch wearable hardware that combines six monitoring modalities (Holter, Extended Holter, Event, MCT, Holter+Event, Holter+MCT) in a single device. Operating as a Certified Independent Diagnostic Testing Facility (IDTF), the company delivers real-time ECG data streaming, proprietary MCOT algorithm analysis, 24/7 monitoring by certified technicians, and integrated billing/reimbursement services to healthcare providers and physician practices across multiple U.S. states.

Is ARTELLA Solutions, Inc. a public or private company?

ARTELLA Solutions, Inc. is a private company. It is classified as corporate owned and is currently operating.

When was ARTELLA Solutions, Inc. founded?

ARTELLA Solutions, Inc. was founded in 2012. It employs 11 to 50 people.

Where is ARTELLA Solutions, Inc. based?

ARTELLA Solutions, Inc. is headquartered in Houston, United States, in the North America region.

How does ARTELLA Solutions, Inc. make money?

Four revenue lines are on record. Mobile Cardiac Telemetry (MCT) Services are the primary driver. The others are technology Licensing (Subscription Model), report Fee Model and hardware Sales.

Who are ARTELLA Solutions, Inc.'s main competitors?

Direct peers on record are iRhythm Technologies, AliveCor, ReactDx (formerly Cardiac Monitoring Services), Medicomp, ScottCare, HeartcoR Solutions and Bardy Diagnostics (Baxter/Hillrom). Broad incumbents are Boston Scientific (Preventice Solutions), Spacelabs Healthcare and Philips (BioTelemetry).

Does ARTELLA Solutions, Inc. have an API?

No public API is recorded for ARTELLA Solutions, Inc..

What industry is ARTELLA Solutions, Inc. in?

ARTELLA Solutions, Inc.'s product category is Remote Cardiac Monitoring Services. Its primary akta.pro industry code is HLAHACAB, Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders), with a secondary code of HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity). Its NAICS code is 54138 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogArtella Solutions Expands Diagnostic Platform into Sleep Medicine Through Strategic Partnership with PranaQArtella Solutions partnered with PranaQ to integrate PranaQ's FDA-cleared Home Sleep Test into its Active State Monitoring platform, creating CARDIOSLEEP for sleep diagnostics. The partnership targets the OSA-afib connection, with up to 50-80% of AFib patients having OSA and CPAP reducing recurrence by 42%.MobiHealthNewsFuture Cardia teams up with Artella Solutions for cardiac deviceFuture Cardia announced an expanded collaboration with Artella Solutions to integrate its remote cardiac monitoring platform into Future Cardia's data ecosystem for its implantable device. The partnership aims to enhance secure ECG data transfer and workflow optimization while the device awaits FDA approval. This development builds on their initial pre-FDA integration efforts to support long-term rhythm assessment.Business Wire BlogFuture Cardia and Artella Solutions Announce Strategic Collaboration for Next-Generation Implantable Cardiac MonitoringFuture Cardia and Artella Solutions announced an expanded strategic collaboration to integrate Artella's remote cardiac monitoring platform with Future Cardia's investigational implantable cardiac monitor. The partnership aims to evaluate data transfer, interoperability, and workflow optimization, supporting ongoing R&D for connected cardiac monitoring.YahooWellysis and Artella Solutions Launch Innovative Remote Cardiac Monitoring Service in the US.Wellysis and Artella Solutions launched a remote cardiac monitoring service in the US, starting in Texas. The service uses the FDA-cleared S-Patch ExL device, which offers 14-day battery life, and includes bundled Samsung smartphones and smartwatches. The partnership will be unveiled at the ACC meeting in April, with AI algorithm clearance pending.PR NewswireWellysis and Artella Solutions Launch Innovative Remote Cardiac Monitoring Service in the US.Wellysis and Artella Solutions launched a remote cardiac monitoring service in the US, starting in Texas. The service uses the FDA-cleared S-Patch ExL device, which offers 14-day battery life, and bundles Samsung smartphones and smartwatches. The partnership will be unveiled at the ACC meeting in April, with AI algorithm FDA clearance pending.GlobeNewswireArtella Solutions, Inc. Announces Expansion into 6 States with New Leadership TeamArtella Solutions announced expansion into Arizona, Florida, Ohio, Michigan, New York, and Pennsylvania, adding industry veterans to its national sales team. The company plans to scale clinical operations and customer service teams to support growth. CEO Sepand Moshiri cited a corporate reorganization aimed at maximizing shareholder value.